• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Translational Development Acquisition Corp. - Ordinary Shares (NQ:TDAC)

10.83 +0.00 (+0.02%)
Delayed Quote Updated: 2:32 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,100
Open 10.82
Bid (Size) 10.81 (77,800)
Ask (Size) 10.83 (1,400)
Prev. Close 10.82
Today's Range 10.81 - 10.83
52wk Range 10.39 - 10.95
Shares Outstanding 5,139,652
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium’s latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology
September 24, 2026
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
August 24, 2026
Appointment intended to strengthen commercialization, scaling and cross-border governance capabilities as ProLogium prepares for its next stage of global growth 
From ProLogium Technology Co., Ltd.
Via GlobeNewswire

Performance

52-Week Range 1.1% below 52-week high
10.83
10.3952W Low 10.9552W High
1 Week 0.7% below 1-week high
10.801W Low 10.901W High

Translational Development Acquisition Corp. - Ordinary Shares (TDAC) traded between $10.39 and $10.95 over the past 52 weeks and last traded at $10.83, 1.1% below its 52-week high. Over the past week it ranged between $10.80 and $10.90.

Past 12 Months
-0.1%
-0.4%
+1.1%
+2.0%
+3.4%
+4.2%
1W -$0.01
1M -$0.04
3M +$0.12
6M +$0.22
YTD +$0.36
1Y +$0.44

TDAC was +4.2% over the past year, +2.0% over six months, +3.4% year to date, -0.1% in the last week.

12 Months vs Market
TDAC
+4.2%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months TDAC returned +4.2% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 1.05× 3-mo avg
Today 30,100 3-mo avg 28.5K
1W
15.8K
1M
7.3K
3M
28.5K
6M
72.1K
YTD
56.5K
1Y
49.5K

TDAC most recently traded 30,100 shares against a 3-month average daily volume of 28.5K.

More News

Read More
News headline image
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
August 19, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
July 28, 2026
From ProLogium Technology Co., Ltd.
Via GlobeNewswire
News headline image
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
May 27, 2026
From ProLogium Technology Co., Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Translational Development Acquisition Corp. - Ordinary Shares publicly traded?
Yes, Translational Development Acquisition Corp. - Ordinary Shares is publicly traded.
What exchange does Translational Development Acquisition Corp. - Ordinary Shares trade on?
Translational Development Acquisition Corp. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares?
The ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares is TDAC on the Nasdaq Stock Market
What is the current price of Translational Development Acquisition Corp. - Ordinary Shares?
The current price of Translational Development Acquisition Corp. - Ordinary Shares is 10.83
When was Translational Development Acquisition Corp. - Ordinary Shares last traded?
The last trade of Translational Development Acquisition Corp. - Ordinary Shares was at 10/16/26 02:32 PM ET
What is the market capitalization of Translational Development Acquisition Corp. - Ordinary Shares?
The market capitalization of Translational Development Acquisition Corp. - Ordinary Shares is 55.65M
How many shares of Translational Development Acquisition Corp. - Ordinary Shares are outstanding?
Translational Development Acquisition Corp. - Ordinary Shares has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap